+1 (704) 266-3234

Anti-Asthmatics And COPD Drugs Global Market Report 2020 Including: 1) By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs 2) By End User: Asthma Patients, COPD Patients 3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce Covering: Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim Gmbh, AstraZeneca

Published on: Aug 2019 | From USD $4000 | Published By: THE BUSINESS RESEARCH COMPANY | Number Of Pages: 200

The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The class of drugs includes Bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.

The global anti-asthmatics and copd drugs market was valued at about $33.4 billion in 2018 and is expected to grow to $42.01 billion at a CAGR of 5.9% through 2022.

North America was the largest region in the anti-asthmatics and COPD drugs market in 2017.

Modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market. Even though there is a decreasing trend of smoking prevalence globally, developing countries such as China, India, Indonesia, and Nigeria among others have increasing smoking prevalence. For instance, the number of tobacco smokers is set to increase by 24 million in Indonesia and by 7 million in Nigeria from 2015 to 2025, and more than 40% of global cigarette consumption is concentrated in China. Consumption of fats including saturated fatty acids which is a risk factor for Asthma and COPD is more in high income countries including USA and Europe. According to WHO, in developed countries more than 35% of total energy requirement is derived from fats when compared to <20% in low income countries, and <25% in lower middle income countries.

Increasing patent expiration of innovator drugs is restraining the anti-asthamatics and COPD drug market. Due to patent expiration, generic drugs are entering the market which are inexpensive when compared to innovator drugs. For example, patent for Advair Diskus inhaler by GSK has expired in 2016, and many players including Novartis, Hikama, and Mylan are trying to get FDA approval for a generic version of the innovator drug.

The use of combination drugs for the treatment of asthma and COPD is increasing. This is due to the greater impact on patient reported outcomes (PROs) compared to monotherapies. For example, combination of short acting beta agonists (SABA) and short acting muscarinic antagnoists (SAMA) are superior compared to either medication alone in improving lung function. The use of combination long acting beta agonists (LABA), and long acting muscarnic antagonists (LAMA) have improved lung function than long acting monotherapy bronchodilators.

Many inhalers that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease. These products aren't necessarily ""official"" direct alternatives to CFC Metered Dose Inhalers, but may in many patients serve as a useful medication that could replace the need for a particular CFC Metered Dose Inhaler. FDA will determine official alternatives by using the criteria established through notice-and-comment rulemaking.

Major players in the market are Novartis AG, Merck & Co, GlaxoSmithKline , Boehringer Ingelheim Gmbh and AstraZeneca.

Anti-Asthmatics And COPD Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and copd drugs market.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the anti-asthmatics and copd drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Asthmatics And COPD Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Drug Class: Bronchodilators , Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs 2) By End User: Asthma Patients, COPD Patients 3) By Distribution Channel: Hospital Pharmacies , Private Clinics , Drug Stores , Retail Pharmacies , E-Commerce

Companies Mentioned: Novartis AG, Merck & Co, GlaxoSmithKline , Boehringer Ingelheim Gmbh, AstraZeneca

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Anti-Asthmatics And COPD Drugs Market Characteristics
3. Anti-Asthmatics And COPD Drugs Market Size And Growth
3.1. Global Anti-Asthmatics And COPD Drugs Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Anti-Asthmatics And COPD Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Anti-Asthmatics And COPD Drugs Market Segmentation
4.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Bronchodilators
Anti-inflammatory Drugs
Monoclonal Antibodies
Combination Drugs
4.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Asthma Patients
COPD Patients
4.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
5. Anti-Asthmatics And COPD Drugs Market Regional And Country Analysis
5.1. Global Anti-Asthmatics And COPD Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Anti-Asthmatics And COPD Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market
6.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
6.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Anti-Asthmatics And COPD Drugs Market
7.1. China Anti-Asthmatics And COPD Drugs Market Overview
7.2. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Anti-Asthmatics And COPD Drugs Market
8.1. India Anti-Asthmatics And COPD Drugs Market Overview
8.2. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Anti-Asthmatics And COPD Drugs Market
9.1. Japan Anti-Asthmatics And COPD Drugs Market Overview
9.2. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Anti-Asthmatics And COPD Drugs Market
10.1. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Anti-Asthmatics And COPD Drugs Market
11.1. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Anti-Asthmatics And COPD Drugs Market
12.1. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Anti-Asthmatics And COPD Drugs Market
13.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
13.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Anti-Asthmatics And COPD Drugs Market
14.1. UK Anti-Asthmatics And COPD Drugs Market Overview
14.2. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Anti-Asthmatics And COPD Drugs Market
15.1. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Anti-Asthmatics And COPD Drugs Market
16.4. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Anti-Asthmatics And COPD Drugs Market
17.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
17.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Anti-Asthmatics And COPD Drugs Market
18.1. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Anti-Asthmatics And COPD Drugs Market
19.1. North America Anti-Asthmatics And COPD Drugs Market Overview
19.2. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Anti-Asthmatics And COPD Drugs Market
20.1. USA Anti-Asthmatics And COPD Drugs Market Overview
20.2. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Anti-Asthmatics And COPD Drugs Market
21.1. South America Anti-Asthmatics And COPD Drugs Market Overview
21.2. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Anti-Asthmatics And COPD Drugs Market
22.1. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Anti-Asthmatics And COPD Drugs Market
23.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
23.2. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Anti-Asthmatics And COPD Drugs Market
24.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
24.2. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Anti-Asthmatics And COPD Drugs Market Competitive Landscape And Company Profiles
25.1. Anti-Asthmatics And COPD Drugs Market Competitive Landscape
25.2. Anti-Asthmatics And COPD Drugs Market Company Profiles
25.2.1. Novartis AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Merck & Co
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. GlaxoSmithKline
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Boehringer Ingelheim Gmbh
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. AstraZeneca
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
27. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Anti-Asthmatics And COPD Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Anti-Asthmatics And COPD Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Global Anti-Asthmatics And COPD Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: China, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: China, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: India, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: India, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: Japan, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: Japan, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: Australia, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Australia, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Indonesia, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: Indonesia, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: South Korea, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: South Korea, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Western Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: Western Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: UK, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: UK, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: Germany, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: Germany, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: France, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: France, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Eastern Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Eastern Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: Russia, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: Russia, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: North America, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: North America, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: USA, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: USA, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: South America, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: South America, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: Brazil, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Brazil, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Middle East, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Middle East, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Africa, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Africa, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 46: Novartis AG Financial Performance
Table 47: Merck & Co Financial Performance
Table 48: GlaxoSmithKline Financial Performance
Table 49: Boehringer Ingelheim Gmbh Financial Performance
Table 50: AstraZeneca Financial Performance


Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Anti-Asthmatics And COPD Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Global Anti-Asthmatics And COPD Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: China, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: China, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: India, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: India, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: Japan, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: Japan, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: Australia, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Australia, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Indonesia, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: Indonesia, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: South Korea, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: South Korea, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Western Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: Western Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: UK, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: UK, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: Germany, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: Germany, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: France, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: France, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Eastern Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Eastern Europe, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: Russia, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: Russia, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: North America, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: North America, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: USA, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: USA, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: South America, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: South America, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: Brazil, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Brazil, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Middle East, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Middle East, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Africa, Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Africa, Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 46: Novartis AG Financial Performance
Figure 47: Merck & Co Financial Performance
Figure 48: GlaxoSmithKline Financial Performance
Figure 49: Boehringer Ingelheim Gmbh Financial Performance
Figure 50: AstraZeneca Financial Performance

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4000
USD $6000
USD $8000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.